Ripretinib Versus Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumor after Treatment with Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial - Bauer, S; Jones, RL; Blay, JY (J Clin Oncol, 2022)
et al.